MedPath

Enhancing Acupuncture Treatment Effect Through Non-invasive Neuromodulation

Not Applicable
Completed
Conditions
Chronic Pain
Registration Number
NCT03716830
Lead Sponsor
Massachusetts General Hospital
Brief Summary

In this study, investigators will examine the brain mechanism behind the synergistic effects of combining acupuncture and transcranial direct current stimulation (tDCS) treatments. Specifically, chronic low back pain (cLBP) patients will be recruited and randomized to one of four groups (30 per group, one month of treatment): 1) verum acupuncture + real tDCS, 2) sham acupuncture + real tDCS, 3) verum acupuncture + sham tDCS, and 4) sham acupuncture + sham tDCS. Investigators will study 1) the longitudinal (one-month) effects of different treatments as indicated by changes in resting state functional connectivity (rsFC), cerebral blood flow (CBF), clinical outcomes of low back pain, and quantitative sensory test (QST) and 2) the association between these changes.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
116
Inclusion Criteria
  • volunteers 18-60 years of age
  • meet the classification criteria of chronic low back pain (having low back pain for more than 6 months), as determined by the referring physician
  • at least 4/10 clinical pain on the 11-point Low Back Pain Numeric Rating Scale (LBP NRS)
  • at least a 10th grade English-reading level; English can be a second language provided that the patients understand all questions used in the assessment measures
Exclusion Criteria
  • history of epilepsy or loss consciousness (LOC)
  • specific causes of back pain (e.g. cancer, fractures, spinal stenosis, infections)
  • complicated back problems (e.g. prior back surgery, medicolegal issues)
  • the intent to undergo surgery during the time of involvement in the study
  • history of cardiac, respiratory, or nervous system disease that, in the investigator's judgment, precludes participation in the study because of a heightened potential for adverse outcomes. For example: asthma or claustrophobia
  • presence of any contraindications to magnetic resonance imaging (MRI) scanning. For example: cardiac pacemaker, metal implants, claustrophobia, pregnancy, inability to remain still in MRI scanner
  • history of medical or psychiatric illness as determined by the investigator
  • history of substance abuse or dependence

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Primary Outcome Measures
NameTimeMethod
Periaqueductal Gray (PAG) Resting State Functional Connectivity (rsFC) Changesdifference between Day 1 (pre-intervention); post-intervention at Week 4 (pre-intervention - Post-intervention)

We investigated whether tDCS and acupuncture treatments modulate resting-state functional connectivity (rsFC) of the periaqueductal gray (PAG). This was evaluated by comparing pre- and post-treatment MRI scans. In this report, we focused on the rsFC between the PAG and the rostral anterior cingulate cortex (rACC, peak MNI coordinate (2, 38, 12) with a 2-mm radius sphere). Functional connectivity values were computed as Pearson's correlation coefficients between the mean time series of predefined regions of interest (ROIs). To improve normality and enable parametric statistical analysis, these correlation coefficients (r) were converted to Fisher z values using the transformation z = 0.5 × ln\[(1 + r) / (1 - r)\]. Higher Fisher z values indicate stronger positive connectivity, whereas lower values indicate weaker or negative connectivity. Changes in Fisher z values from baseline to post-intervention reflect the degree and direction of connectivity modulation.

Secondary Outcome Measures
NameTimeMethod
Clinical Outcomes as Measured by LBP Intensity ScoresDifference between the Day 1 (pre-intervention) and post-intervention at Week 4 (post-intervention - pre-intervention)

The Low Back Pain Numeric Rating Scale (LBP NRS) is a standardized adaptation of the Pain Numeric Rating Scale for assessing pain intensity specifically related to the lower back. It uses an 11-point scale from 0 ("no low back pain") to 10 ("worst low back pain imaginable"), allowing patients to rate their pain over the past week.

Cerebral Blood Flow (CBF) Differences Before and After TreatmentsDay 1 (pre-intervention); post-intervention at Week 4

Investigators will examine Cerebral blood flow (CBF) changes before and after treatment in several pain-related brain areas. Cerebral blood flow represents the volume of blood delivered to brain tissue per unit time, CBF data will be collected during arterial spin labeling (ASL) scans that will take place before the first treatment and after the last treatment. Images from these scans will be aggregated to an average CBF-weighted image to be used for analysis. In this report, we focused on bilateral postcentral Gyrus (MNI coordinate: +/-18, -34, 56, 2 mm sphere)

Quantitative Sensory Testing (QST) DifferencesDay 1 (pre-intervention); post-intervention at Week 4 (pre-intervention - post-intervention)

Participants' quantitative sensory testing (QST) ratings were analyzed before and after all treatments. Here, we report the heat pain threshold measured around the affected lower back area.

Primary Motor Cortex (M1) rsFC Changes Before and After 4-week TreatmentsDay 1 (pre-intervention); post-intervention at Week 4 (pre-intervention - post-intervention)

We investigated whether tDCS and acupuncture treatments modulate resting-state functional connectivity (rsFC) of the M1. This was evaluated by comparing pre- and post-treatment MRI scans. In this report, we focused on the rsFC between the PAG and the rostral anterior cingulate cortex (rACC), using a seed defined by the rACC peak MNI coordinate (0, 34, 20) with a 2-mm radius sphere.

Functional connectivity values were computed as Pearson's correlation coefficients between the mean time series of predefined regions of interest (ROIs). To improve normality and enable parametric statistical analysis, these correlation coefficients (r) were converted to Fisher z values using the transformation z = 0.5 × ln\[(1 + r) / (1 - r)\]. Higher Fisher z values indicate stronger positive connectivity, whereas lower values indicate weaker or negative connectivity. Changes in Fisher z values from baseline to post-intervention

Trial Locations

Locations (1)

Massachusetts General Hospital

🇺🇸

Charlestown, Massachusetts, United States

Massachusetts General Hospital
🇺🇸Charlestown, Massachusetts, United States
Maya Eshel
Contact
meshel@mgh.harvard.edu
Rachel Dao
Contact
rdao@mgh.harvard.edu

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.